Dengue viral infections

Postgraduate Medical Journal

Volumn 80, Issue 948, 2004, Pages 588-601

  Malavige, G N ^b   Fernando, S ^b   Fernando, D J ^b,c   Seneviratne, Suranjith L ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF SRI JAYEWARDENEPURA   (Sri Lanka)

^c KING S MILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANTIEMETIC AGENT; ANTIPYRETIC AGENT; CIMETIDINE; CITRONELLAL; DENGUE VACCINE; DICLOFENAC; DIETHYLTOLUAMIDE; DNA VACCINE; DOMPERIDONE; ELECTROLYTE; FRESH FROZEN PLASMA; GASTROINTESTINAL MUCOSA PROTECTIVE AGENT; IMMUNOGLOBULIN M ANTIBODY; INFUSION FLUID; INOTROPIC AGENT; INSECT REPELLENT; INSECTICIDE; LIVE VACCINE; MALATHION; NEUTRALIZING ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PARACETAMOL; RECOMBINANT VACCINE; THROMBOCYTE CONCENTRATE; UNINDEXED DRUG; UREA; VIRUS PROTEIN; VIRUS VECTOR;

AEDES; AEDES AEGYPTI; AEDES ALBOPICTUS; AEDES POLYNESIENSIS; ANTIBODY RESPONSE; ANTIBODY TITER; BLOOD TRANSFUSION; BRAIN DISEASE; CLINICAL FEATURE; CLINICAL PROTOCOL; COLLOID; CRYOPRECIPITATE; CRYSTALLOID; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS; DRUG DOSE REGIMEN; EARLY DIAGNOSIS; FEVER; FLUID BALANCE; GASTROINTESTINAL HEMORRHAGE; GENETIC PREDISPOSITION; HOSPITAL ADMISSION; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LIVER FAILURE; LIVER INJURY; MORBIDITY; MORTALITY; MOSQUITO; NONHUMAN; ORAL REHYDRATION THERAPY; RESUSCITATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SERODIAGNOSIS; SHOCK; STOMACH DISEASE; THROMBOCYTE TRANSFUSION; TREATMENT PLANNING; VACCINATION; VECTOR CONTROL; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS MYOCARDITIS; VIRUS STRAIN; VIRUS TYPING; VIRUS VIRULENCE;

AFRICA; AMERICAS; ANIMALS; ANTIBODIES, VIRAL; ASIA; BRAIN DISEASES; CULICIDAE; CYTOKINES; DENGUE; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; HUMANS; IMMUNITY, CELLULAR; INSECT VECTORS; LIVER FAILURE; MOSQUITO CONTROL; MYOCARDITIS; SHOCK; VIRAL VACCINES;

EID: 6344233465     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2004.019638     Document Type: Review

References (156)

1. Pinheira FP, Corber SJ. Global situation of dengue and dengue haemorrhagic fever and its emergence in the Americas. World Health Stat Q 1997;50:161-8.
2. World Health Organisation. Prevention and control of dengue and dengue haemorrhagic fever: comprehensive guidelines. WHO Regional publication, SEARO, No 29, 1999.
3. Halstead SB. Is there an inapparent dengue explosion? Lancet 1999;353:1100-1.
4. Nimmannitya S. Dengue haemorrhagic fever: current issues and future research. Asian-Oceanian Journal of Paediatrics and Child Health 2002;1:1-21.
5. King CC, Wu YC, Chao DY, et al. Major epidemics of dengue in Taiwan in 1981-2000: related to intensive virus activities in Asia. Dengue Bulletin 2000;24:1-10.
6. Endy TP, Nisalak A, Chunsuttiwat S, et al. Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 2002;156:52-9.
7. Messer WB, Gubler DJ, Harris E, et al. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis 2003;9:800-9.
8. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis 2002;2:33-42.
9. Rico-Hesse R. Microevolution and virulence of dengue viruses. Adv Virus Res 2003;59:315-41.
10. Sukri NC, Laras K, Wandra T, et al. Transmission of epidemic dengue hemorrhagic fever in easternmost Indonesia. Am J Trap Med Hyg 2003;68:529-35.
11. Nisalak A, Endy TP, Nimmanitya S, et al. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg 2003;68:191-202.
12. Chareonsook O, Foy HM, Teeraratkul A, et al. Changing epidemiology of dengue hemorrhagic fever in Thailand. Epidemiol Infect 1999;122:161-6.
13. Ha DQ, Tien NT, Huong VT, et al. Dengue epidemic in Southern Vietnam, 1998. Emerg Infect Dis 2000;6:422-5.
14. Anonymous. Dengue in the WHO Western Pacific Region. Weekly Epidemiological Record 1998;72:273-80.
15. Munasinghe DR, Amarasekera PJ, Fernando CF. An epidemic of dengue-like fever in Ceylon (chikungunya) - a clinical and haematological study. Ceylon Med J 1966;11:129-42.
16. Messer WB, Vitarana UT, Sivananthan K, et al. Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever. Am J Trop Med Hyg 2002;66:765-73.
17. Dar L, Broor S, Sengupta S, et al. First major outbreak of dengue hemorrhagic fever in Delhi, India. Emerg Infect Dis 1999;5:589-90.
18. Qiu FX, Gubler DJ, Liu JC, et al. Dengue in China: a clinical review. Bull World Health Organ 1993;71:349-59.
19. Fan WF, Yu SR, Cosgriff TM. The reemergence of dengue in China. Rev Infect Dis 1989;11(suppl 4):S847-53.
20. Tadano M, Okuno Y, Fukunaga T, et al. Retrospective serological studies on dengue epidemics in Osaka and Okinawa. Biken J 1983;26:165-7.
21. Guzman MG, Kouri G, Vazquez S, et al. DHF epidemics in Cuba, 1981 and 1997: some interesting observations. Dengue Bulletin 1999;23:39-43.
22. Guzman Tirado MG, Kouri Flores G, Bravo Gonzalez JR. Emergence of dengue hemorrhagic fever in the Americas. Reemergence of dengue. Rev Cubana Med Trop 1999;51:5-13.
23. Guzman MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 2003;27:1-13.
24. Halstead SB, Streit TG, Lafontant JG, et al. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg 2001;65:180-3.
25. Guzman MG, Kouri G. Advances in dengue diagnosis. Clin Diagn Lab Immunol 1996;3:621-7.
26. Young PR, Hilditch PA, Bletchly C, et al. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol 2000;38:1053-7.
27. Libraty DH, Young PR, Pickering D, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 2002;186:1165-8 (Epub 16 September 2002).
28. Cardosa MJ, Wang SM, Sum MS, et al. Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses. BMC Microbiol 2002;2:9 (Epub 5 May2002).
29. Thavara U, Tawatsin A, Chansang C, et al. Larval occurrence, oviposition behavior and biting activity of potential mosquito vectors of dengue on Samui Island, Thailand. J Vector Ecol 2001;26:172-80.
30. Perich MJ, Davila G, Turner A, et al. Behavior of resting Aedes aegypti (culicidae: diptera) and its relation to ultra-low volume adulticide efficacy in Panama City, Panama. J Med Entomol 2000;37:541-6.
31. Vezzani D, Schweigmann N. Suitability of containers from different sources as breeding sites or Aedes aegypti (L) in a cemetery of Buenos Aires City, Argentina. Mem Inst Oswaldo Cruz 2002;97:789-92.
32. Thu HM, Aye KM, Thein S. The effect of temperature and humidity on dengue virus propagation in Aedes aegypti mosquitos. Southeast Asian J Trop Med Public Health 1998;29:280-4.
33. Watts DM, Burke DS, Harrison BA, et al. Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am J Trop Med Hyg 1987;36:143-52.
34. Platt KB, Linthicum KJ, Myint KS, et al. Impact of dengue virus infection on feeding behavior of Aedes aegypti. Am J Trop Med Hyg 1997;57:119-25.
35. Joshi V, Mourya DT, Sharma RC. Persistence of dengue-3 virus through transovarial transmission passage in successive generations of Aedes aegypti mosquitoes. Am J Trop Med Hyg 2002;67:158-61.
36. Rosen L. Sexual transmission of dengue viruses by Aedes albopictus. Am J Trop Med Hyg 1987;37:398-402.
37. Ahmed FU, Mahmood CB, Sharma JD, et al. Dengue fever and dengue haemorrhagic fever in children the 2000 out break in Chittatong, Bangladesh. Dengue Bulletin 2001;25:33-9.
38. Narayanan M, Aravind MA, Thilothammal N, et al. Dengue fever epidemic in Chennai - a study of clinical profile and outcome. Indian Pediatr 2002;39:1027-33.
39. Hongsiriwon S. Dengue hemorrhagic fever in infants. Southeast Asian J Trop Med Public Health 2002;33:49-55.
40. Pancharoen C, Mekmullica J, Thisyakorn U. Primary dengue infection: what are the clinical distinctions from secondary infection? Southeast Asian J Trop Med Public Health 2001;32:476-80.
41. Kabra SK, Jain Y, Pandey RM, et al. Dengue haemorrhagic fever in children in the 1996 Delhi epidemic. Trans R Soc Trop Med Hyg 1999;93:294-8.
42. Swasdivorn S, Vibulvatonakit S, Sasavatpakde RN, et al. Efficicacy of clinical diagnosis pod dengue fever in pediatric age groups as determined by the WHO case definition 1997 in Thailand. Dengue Bulletin 2001;25:56-64.
43. Kalayanarooj S, Nimmannitya S, Suntayakorn S, et al. Can doctors make an accurate diagnosis of dengue infections at an early stage? Dengue Bulletin 1999;23:1-9.
44. Martinez E, Guzman MG, Valdes M, et al. Dengue fever and hemorrhagic dengue in infants with a primary infection. Rev Cubana Med Trop 1993;45:97-101.
45. Halstead SB, Lan NT, Myint TT, et al. Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg Infect Dis 2002;8:1474-9.
46. Mendez A, Gonzalez G. Dengue haemorrhagic fever in children: ten years of clinical experience. Biomedica 2003;23:180-93.
47. Srivastava VK, Suri S, Bhasin A, et al. An epidemic of dengue haemorrhagic fever and dengue shock syndrome in Delhi: a clinical study. Ann Trop Paediatr 1990;10:329-34.
48. Anuradha S, Singh NP, Rizvi SN, et al. The 1996 outbreak of dengue hemorrhagic fever in Delhi, India. Southeast Asian J Trop Med Public Health 1998;29:503-6.
49. Richards AL, Bagus R, Baso SM, et al. The first reported outbreak of dengue hemorrhagic fever in Irian Jaya, Indonesia. Am J Trop Med Hyg 1997;57:49-55.
50. Aggarwal A, Chandra J, Aneja S, et al. An epidemic of dengue hemorrhagic fever and dengue shock syndrome in children in Delhi. Indian Pediatr 1998;35:727-32.
51. Guzman MG, Alvarez M, Rodriguez R, et al. Fatal dengue hemorrhagic fever in Cuba, 1997. Int J Infect Dis 1999;3:130-5.
52. Lucus GN, Karunatilaka DH, Wijesuriya AP, et al. Guidelines for management of dengue haemorrhagic fever (DHF). Sri Lanka: Sri Lankan College of Paediatricians, 2003.
53. Kalayanarooj S, Chansiriwongs V, Nimmannitya S. Dengue patients at the Children's Hospital, Bangkok: 1995-1999. Review. Dengue Bulletin 2002;26:33-43.
54. Kabra SK, Jain Y, Singhal T, et al. Dengue hemorrhagic fever: clinical manifestations and management. Indian J Pediatr 1999;66:93-101.
55. Wali JP, Biswas A, Handa R, et al. Dengue haemorrhagic fever in adults: a prospective study of 110 cases. Trop Doct 1999;29:27-30.
56. Guzman MG, Kouri GP, Bravo J, et al. Dengue haemorrhagic fever in Cuba. II. Clinical investigations. Trans R Soc Trop Med Hyg 1984;78:239-41.
57. Kabra SK, Jain Y, Pandey RM, et al. Dengue haemorrhagic fever in children in the 1996 Delhi epidemic. Trans R Soc Trop Med Hyg 1999;93:294-8.
58. Agarwal R, Kapoor S, Nagar R, et al. A clinical study of the patients with dengue hemorrhagic fever during the epidemic of 1996 at Lucknow, India. Southeast Asian J Trop Med Public Health 1999;30:735-40.
59. Kalayanarooj S, Vaughn DW, Nimmannitya S, et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997;176:313-21.
60. Huang YH, Liu CC, Wang ST, et al. Activation of coagulation and fibrinolysis during dengue virus infection. Med Virol 2001;63:247-51.
61. Van Gorp EC, Suharti C, Mairuhu AT, et al. Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. Clin Infect Dis 2002;34:1150-3.
62. Pancharoen C, Rungsarannont A, Thisyakorn U. Hepatic dysfunction in dengue patients with various severity. J Med Assoc Thai 2002;85(suppl 1):S298-301.
63. Huerre MR, Lan NT, Marianneau P, et al. Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children. Virchows Arch 2001;438:107-15.
64. Mohan B, Patwari AK, Anand VK. Hepatic dysfunction in childhood dengue infection. J Trop Pediatr 2000;46:40-3.
65. Kalayanarooj S, Nimmannitya S. Clinical and Laboratory presentations of of Dengue patients with diiferent serotypes. Dengue Bulletin 2000;24:53-9.
66. Nguyen TL, Nguyen TH, Tieu NT. The impact of dengue haemorrhagic fever on liver function. Res Virol 1997;148:273-7.
67. Cam BV, Fonsmark L, Hue NB, et al. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg 2001;65:848-51.
68. Lum LC, Lam SK, Choy YS, et al. Dengue encephalitis: a true entity? Am J Trop Med Hyg 1996;54:256-9.
69. Chaturvedi UC, Dhawan R, Khanna M, et al. Breakdown of the blood-brain barrier during dengue virus infection of mice. J Gen Virol 1991;72(pt 4):859-66.
70. Wali JP, Biswas A, Chandra S, et al. Cardiac involvement in dengue haemorrhagic fever. Int J Cardiol 1998;64:31-6.
71. Kabra SK, Juneja R, Madhulika, et al. Myocardial dysfunction in children with dengue haemorrhagic fever. Natl Med J India 1998;11:59-61.
72. King CA, Marshall JS, Alshurafa H, et al. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol 2000;74:7146-50.
73. Ling Jun Ho, Wang JJ, Shaio MF, et al. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol 2001;166:1499-506.
74. Huang YH, Lei HY, Liu HS, et al. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 2000;63:71-5.
75. Libraty DH, Young PR, Pickering D, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 2002;186:1165-8.
76. Littaua R, Kurane I, Ennis FA. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol 1990;144:3183-6.
77. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988;239:476-81.
78. Yang KD, Yeh WT, Yang MY, et al. Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production. J Med Virol 2001;63:150-7.
79. Lin CF, Lei HY, Shiau AL, et al. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J Immunol 2002;169:657-64.
80. Koraka P, Suharti C, Setiati TE, et al. Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J Clin Microbiol 2001;39:4332-8.
81. Thein S, Aaskov J, Myint TT, et al. Changes in levels of anti-dengue virus IgG subclasses in patients with disease of varying severity. J Med Virol 1993;40:102-6.
82. Koraka P, Murgue B, Deparis X, et al. Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity. J Med Virol 2003;70:91-8.
83. Miguez-Burbano MJ, Jaramillo CA, Palmer G, et al. Total immunoglobulin E levels and dengue infection on San Andres Island, Colombia. Clin Diagn Lab Immunol 1999;6:624-6.
84. Chaturvedi UC, Elbishbishi EA, Agarwal R, et al. Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. J Med Virol 1999;59:335-40.
85. Hathirat P, Isarangkura P, Srichaikul T, et al. Abnormal hemostasis in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1993;24(suppl 1):80-5.
86. Lin CF, Lei HY, Liu CC, et al. Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol 2001;63:143-9.
87. Wang S, He R, Patarapotikul J, et al. Antibody-enhanced binding of dengue-2 virus to human platelets. Virology 1995;213:254-7.
88. Boonpucknavig S, Vuttiviroj O, Bunnag C, et al. Demonstration of dengue antibody complexes on the surface of platelets from patients with dengue hemorrhagic fever. Am J Trop Med Hyg 1979;28:881-4.
89. Gilbreath MJ, Pavanand K, MacDermott RP, et al. Cold-reactive immunoglobulin M antilymphocyte antibodies directed against B cells in Thai children with dengue hemorrhagic fever. J Clin Microbiol 1983;17:672-6.
90. Mustafa AS, Elbishbishi EA, Agarwal R, et al. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 2001;30:229-33.
91. Vitarana T, de Silva H, Withana N, et al. Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. Ceylon Med J 1991;36:63-5.
92. Christine A King, Marshall JS, Alshurafa H, et al. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol 2000;74:7146-50.
93. Chaturvedi UC, Elbishbishi EA, Agarwal R, et al. Cytotoxic factor-autoantibodies: possible role in the pathogenesis or dengue haemorrhagic fever. FEMS Immunol Med Microbiol 2001;30:181-6.
94. Juffrie M, Meer GM, Hack CE, et al. Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am J Trop Med Hyg 2001;65:70-5.
95. Raghupathy R, Chaturvedi UC, Al-Sayer H, et al. Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol 1998;56:280-5.
96. Juffrie M, van Der Meer GM, Hack CE, et al. Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation. Infect Immun 2000;68:702-7.
97. Kurane I, Meager A, Ennis FA. Induction of interferon alpha and gamma from human lymphocytes by dengue virus-infected cells. J Gen Virol 1986;67(pt 8):1653-61.
98. Kurane I, Ennis FA. Induction of interferon alpha from human lymphocytes by autologous, dengue virus-infected monocytes. J Exp Med 1987;166:999-1010.
99. Kurane I, Innis BL, Nimmannitya S, et al. High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg 1993;48:222-9.
100. Green S, Vaughn DW, Kalayanarooj S, et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999;179:755-62.
101. Libraty DH, Pichyangkul S, Ajariyakhajorn C, et al. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol 2001;75:3501-8.
102. Kontny U, Kurane I, Ennis FA. Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol 1988;62:3928-33.
103. Ho LJ, Wang JJ, Shaio MF, et al. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol 2001;166:1499-506.
104. Azeredo EL, Zagne SM, Santiago MA, et al. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology 2001;204:494-507.
105. Mentor NA, Kurane I. Dengue virus infection of human T lymphocytes. Acta Virol 1997;41:175-6.
106. Sierra B, Garcia G, Ferez AB, et al. Long-term memory cellular immune response to dengue virus after a natural primary infection. Int J Infect Dis 2002;6:125-8.
107. Kurane I, Innis BL, Nimmannitya S, et al. Human immune responses to dengue viruses. Southeast Asian J Trop Med Public Health 1990;21:658-62.
108. Mathew A, Kurane I, Rothman AL, et al. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest 1996;9B:1684-91.
109. Kurane I, Brinton MA, Samson AL, et al. Dengue virus-specific, human CD4+ CDS- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J Virol 1991;65:1823-8.
110. Gagnon SJ, Ennis FA, Rothman AL. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J Virol 1999;73:3623-9.
111. Kurane I, Innis BL, Nisolak A, et al. Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest 1989;83:506-13.
112. Sarasambath S, Suvatte V, Homchampa P. Kinetics of lymphocyte subpapulations in dengue hemorrhagic fever/dengue shock syndrome. Southeast Asian J Trop Med Public Health 1988;19:649-56.
113. Lo Russa VF, Innis BL. Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clin Haematol 1995;8:249-70.
114. Liu CC, Huang KJ, Lin YS, et al. Transient CD4/CD8 ratio inversion and aberrant immune activation during dengue virus infection. J Med Virol 2002;68:241-52.
115. Kurane I, Innis BL, Nimmannitya S, et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CDS, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest 1991;88:1473-80.
116. Kurane I, Innis BL, Hoke CH Jr, et al. T cell activation in vivo by dengue virus infection. J Clin Lab Immunol 1995;46:35-40.
117. Mathew A, Kurane I, Green S, et al. Impaired T cell proliferation in acute dengue infection. J Immunol 1999;162:5609-15.
118. Guzman MG, Kouri GP, Bravo J, et al. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg 1990;42:179-84.
119. Guzman MG, Kouri G, Bravo J, et al. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis 2002;6:118-24.
120. Kabra SK, Jain Y, Pandey RM, et al. Dengue haemorrhagic fever in children in the 1996 Delhi epidemic. Trans R Soc Trop Med Hyg 1999;93;294-8.
121. Thisyakorn U, Nimmannitya S. Nutritional status of children with dengue hemorrhagic fever. Clin Infect Dis 1993;16:295-7.
122. Cunha RV, Schatzmayr HG, Miagostovich MP, et al. Dengue epidemic in the State of Rio Grande do Norte, Brazil, in 1997. Trans R Soc Trop Med Hyg 1999;93:247-9.
123. Bravo JR, Guzman MG, Kouri GP. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hyg 1987;81:816-20.
124. Guzman MG, Kouri G, Soler M. Dengue 2 virus enhancement in asthmatic and non asthmatic individual. Mem Inst Oswaldo Cruz 1992;87:559-64.
125. Halstead SB, Streit TG, Lafontant JG, et al. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg 2001;65:180-3.
126. Loke H, Bethell DB, Phuonq CXT, et al. Strong HLA class I restricted responses in dengue haemorrhagic fever: a double edged sword? J Infect Dis 2001;184:1369-73.
127. Stephens HA, Klaythong R, Sirikong M, et al. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 2002;60:309-18.
128. Loke H, Bethell D, Phuong CX, et al. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor Ila genes. Am J Trop Med Hyg 2002;67:102-6.
129. Henchal EA, McCown JM, Seguin MC, et al. Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay. Am J Trop Med Hyg 1983;32:164-9.
130. Branch SL, Levett PN. Evaluation of four methods for detection of immunoglobulin M antibodies to dengue virus. Clin Diagn Lab Immunol 1999;6:555-7.
131. Kuno G, Gubler DJ, Santiago de Weil NS. Antigen capture ELISA for the identification of dengue viruses. J Virol Methods 1985;12:93-103.
132. Nawa M, Ichikawa Y, Inouye S. Serotyping of dengue viruses by an enzyme-linked immunosorbent assay. Jpn J Med Sci Biol 1985;38:217-21.
133. Velathanthiri N, Fernando R, Fernando S, et al. Development of a polymerase chain reaction (PCR) for the detection of dengue virus and its sera types. Abstract presented at the Sri Lanka College of Microbiologists annual sessions, 2002.
134. De Paula SO, Pires Neto RJ, Correa JA, et al. The use of reverse transcription-polymerase chain reaction (RT-PCR) for the rapid detection and identification of dengue virus in an endemic region: a validation study. Trans R Soc Trop Med Hyg 2002;96:266-9.
135. Tripathi BK, Gupta B, Sinha RS, et al. Experience in adult population in dengue outbreak in Delhi. J Assoc Physicians India 1998;46:273-6.
136. Workshop on case management of dengue hemorrhagic fever, June 2002, Bangkok, Thailand.
137. Halliday MA, Segar WE. Maintenance need for water: in parenteral fluid therapy. Pediatrics 1957;19:823.
138. Wills B. Volume replacement in dengue shock syndrome. Dengue Bulletin 2001;25:50-5.
139. Chuansumrit A, Phimolthares V, Tardtong P, et al. Transfusion requirements in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 2000;31:10-4.
140. Isarangkura P, Tuchinda S. The behavior of transfused platelets in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1993;24(suppl 1):222-4.
141. Soni A, Chugh K, Sachdev A, et al. Management of dengue fever in ICU. Indian J Pediatr 2001;68:1051-5.
142. Dung NM, Day NP, Tam DT, et al. Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis 1999;29:787-94.
143. Van Benthem BH, Khantikul N, Panart K, et al. Knowledge and use of prevention measures related to dengue in northern Thailand. Trap Med Int Health 2002;7:993-1000.
144. Kay BH, Nam VS, Tien TV, et al. Control of aedes vectors of dengue in three provinces of Vietnam by use of mesocyclops (copepoda) and community-based methods validated by entomologic, clinical, and serological surveillance. Am J Trop Med Hyg 2002;66:40-8.
145. Gratz NG. Space sprays for the control of Aedes aegypti in South-East Asia and the Western Pacific. Dengue Bulletin 1999;24:80-4.
146. Huong VD, Ngoc NTB. Susceptibility of Aedes aegypti to insecticides. Dengue Bulletin 1999;23:85-8.
147. Katyal R, Tewari P, Rahman SJ, et al. Susceptibility status of immature and adult stages of Aedes aegypti against conventional insecticides in Delhi, India. Dengue Bulletin 2001;25:84-7.
148. Lee HL, Khadri MS, Chiang YF. Preliminary field evaluation of the combined adulticidal, larvicidal, and wall residual activity of ULV-applied bifenthrin against mosquitoes. J Vector Ecol 1997;22:146-9.
149. Castle T, Amador M, Rawlins S, et al. Absence of impact of aerial malathion treatment on Aedes aegypti during a dengue outbreak in Kingston, Jamaica. Rev Panam Solud Publica 1999;5:100-5.
150. Perikov Y. Development of dengue vaccine. Dengue Bulletin 2000;24:71-76.
151. Kanesa-thasan N, Sun W, Kim-Ahn G, et al. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine 2001;19:3179-88.
152. Sabcharean A, Lang J, Chanthavanich P, et al. Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses. Am J Trop Med Hyg 2002;66:264-72.
153. Rabablert J, Dharakul T, Yoksan S, et al. Dengue virus specific T cell responses to live attenuated monovalent dengue-2 and tetravalent dengue vaccines. Asian Pac J Allergy Immunol 2000;18:227-35.
154. Rothman AL, Kanesa-thasan N, West K, et al. Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine. Vaccine 2001;19:4694-9.
155. Raviprakash K, Marques E, Ewing D, et al. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF. Virology 2001;290:74-82.
156. Simmons M, Murphy GS, Kochel T, et al. Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine. Am J Trop Med Hyg 2001;65:420-6.